Janus Henderson Group PLC Aurinia Pharmaceuticals Inc. Transaction History
Janus Henderson Group PLC
- $187 Billion
- Q3 2024
A detailed history of Janus Henderson Group PLC transactions in Aurinia Pharmaceuticals Inc. stock. As of the latest transaction made, Janus Henderson Group PLC holds 49,331 shares of AUPH stock, worth $437,072. This represents 0.0% of its overall portfolio holdings.
Number of Shares
49,331
Previous 49,331
-0.0%
Holding current value
$437,072
Previous $281,000
28.47%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding AUPH
# of Institutions
208Shares Held
58.6MCall Options Held
1.14MPut Options Held
1.51M-
Black Rock Inc. New York, NY9.27MShares$82.2 Million0.0% of portfolio
-
Armistice Capital, LLC New York, NY8.2MShares$72.7 Million1.0% of portfolio
-
Tang Capital Management LLC San Diego, CA7.23MShares$64.1 Million4.52% of portfolio
-
Nea Management Company, LLC Timonium, MD3.97MShares$35.2 Million2.22% of portfolio
-
State Street Corp Boston, MA2.95MShares$26.1 Million0.0% of portfolio
About Aurinia Pharmaceuticals Inc.
- Ticker AUPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 141,892,000
- Market Cap $1.26B
- Description
- Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license...